|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||

* From the Departments of Surgical Oncology (Drs. van Geel and van der Sijp), Radiotherapy (Dr. Jansen), and Pulmonary-Oncology (Dr. van Klaveren), Erasmus Medical Center/Daniel den Hoed, Rotterdam, the Netherlands.
Dr. van der Sijp is currently at the Department of Surgical Oncology, VU Medical Center, Amsterdam, the Netherlands.
Correspondence to: A. N. van Geel, MD, PhD, Department of Surgical Oncology, Erasmus Medical Center/Daniel den Hoed, Groene Hilledijk 301, 3075 EA Rotterdam, the Netherlands; e-mail: geel{at}chih.azr.nl
Study objectives: Relapse-free survival in patients with sulcus superior tumors.
Design: Prospective registration study.
Setting: Department of surgical oncology of a university hospital.
Patients: Twenty-one patients treated with preoperative radiotherapy (46 Gy), lobectomy and chest-wall resection, and intraoperative radiotherapy (10 Gy).
Results: After a median follow-up of 18 months, 18 patients (85%) were free from locoregional relapse, while 8 patients were still alive.
Conclusions: The results show that this protocol can achieve excellent local tumor control and can even be used for palliative treatment.
Key Words: brachytherapy chest wall resection external beam radiotherapy lung cancer sulcus superior tumor
This article has been cited by other articles:
![]() |
K. F. Kwong, M. J. Edelman, M. Suntharalingam, L. B. Cooper, Z. Gamliel, W. Burrows, P. Hausner, L. A. Doyle, and M. J. Krasna High-dose radiotherapy in trimodality treatment of Pancoast tumors results in high pathologic complete response rates and excellent long-term survival J. Thorac. Cardiovasc. Surg., June 1, 2005; 129(6): 1250 - 1257. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |